Private equity

Private equity is one of the firm’s outstanding skills and our team is particularly renowned for its expertise in this domain.

We advise numerous investment funds on the creation of their management companies, on the constitution of fund regulations and on their actual investments, whether in venture capital, leveraged buyouts or owner buyouts [LBOs/OBOs].

We know that finding funding can be tricky, so we also support companies that want to finance themselves through private equity (fundraising), particularly in the biotechnologies and new technologies sectors. We advise management teams and assist them as they seek financing and set up management packages.

In close collaboration with the firm’s other teams, we offer pragmatic advice from start to finish that is tailored to our clients’ needs and strive to ensure that their legal and fiscal strategies will help them create value.


Venture capital and development capital

- Drafting appropriate legal documentation (letter of intent, shareholders’ agreement, investment protocol, asset and liability guarantees, etc.)
- Legal audits
- Issuing complex investment securities (preference shares, convertible or reimbursable bonds, etc.)
- Advising funds on the legal aspects of their investment strategy (terms and conditions governing capital contributions, sharing the internal yield rate [TRI], governance of companies, non-competition clauses, etc.)

Mezzanine financing and leverage operations

- Financing operations using complex bonds
- Leverage operations, i.e., LBO, MBO, MBI or OBO.

Important missions

- Many cases of convertible bond investment, mezzanine financing, OBOs and LBOs, particularly for Bpifrance Investissement.
- Assistance setting up a private investment fund.
- Assistance to a biotechnology company with its successive calls for funding, raising a total sum of over €60 million, and then with its entry on the stock exchange.
- Assistance to an independent French media company that publishes websites dedicated to new technologies in raising €22.5 million in funds.
- Assistance raising funds of several million euros from French and American investors for a company specialized in the development of in vivo cellular imaging systems designed for biomedical applications.